Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Percutaneous Treatment of Carpal Tunnel Syndrome With Scan

NCT: NCT02514317 · COMPLETED

NCT IDNCT02514317
StatusCOMPLETED
Start Date2012-01
Completion2013-04

Brief Summary

The objective of the study is to evaluate in patients suffering from carpal tunnel syndrome resistant to medical treatment, clinical course after percutaneous treatment under ultrasound guidance. 40 patients will be included in the study. The following parameters will be evaluated: patient satisfaction, pain, functional disability, quality of life and time to return to work. The medico-economic aspect will be analyzed.

Frequently Asked Questions

What is Percutaneous Treatment of Carpal Tunnel Syndrome With Scan?

Percutaneous Treatment of Carpal Tunnel Syndrome With Scan is a clinical trial registered under NCT02514317. Current status: COMPLETED.

What is the status of NCT02514317?

The current status of NCT02514317 (Percutaneous Treatment of Carpal Tunnel Syndrome With Scan) is: COMPLETED.

When did Percutaneous Treatment of Carpal Tunnel Syndrome With Scan start?

Percutaneous Treatment of Carpal Tunnel Syndrome With Scan started on 2012-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.